116 related articles for article (PubMed ID: 14507915)
1. MDM2 and promyelocytic leukemia antagonize each other through their direct interaction with p53.
Zhu H; Wu L; Maki CG
J Biol Chem; 2003 Dec; 278(49):49286-92. PubMed ID: 14507915
[TBL] [Abstract][Full Text] [Related]
2. Physical and functional interactions between PML and MDM2.
Wei X; Yu ZK; Ramalingam A; Grossman SR; Yu JH; Bloch DB; Maki CG
J Biol Chem; 2003 Aug; 278(31):29288-97. PubMed ID: 12759344
[TBL] [Abstract][Full Text] [Related]
3. The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.
Louria-Hayon I; Grossman T; Sionov RV; Alsheich O; Pandolfi PP; Haupt Y
J Biol Chem; 2003 Aug; 278(35):33134-41. PubMed ID: 12810724
[TBL] [Abstract][Full Text] [Related]
4. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
Bernardi R; Scaglioni PP; Bergmann S; Horn HF; Vousden KH; Pandolfi PP
Nat Cell Biol; 2004 Jul; 6(7):665-72. PubMed ID: 15195100
[TBL] [Abstract][Full Text] [Related]
5. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization.
Kurki S; Latonen L; Laiho M
J Cell Sci; 2003 Oct; 116(Pt 19):3917-25. PubMed ID: 12915590
[TBL] [Abstract][Full Text] [Related]
6. PML enhances the regulation of p53 by CK1 in response to DNA damage.
Alsheich-Bartok O; Haupt S; Alkalay-Snir I; Saito S; Appella E; Haupt Y
Oncogene; 2008 Jun; 27(26):3653-61. PubMed ID: 18246126
[TBL] [Abstract][Full Text] [Related]
7. Impairment of p53 acetylation, stability and function by an oncogenic transcription factor.
Insinga A; Monestiroli S; Ronzoni S; Carbone R; Pearson M; Pruneri G; Viale G; Appella E; Pelicci P; Minucci S
EMBO J; 2004 Mar; 23(5):1144-54. PubMed ID: 14976551
[TBL] [Abstract][Full Text] [Related]
8. BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction.
Yang Q; Liao L; Deng X; Chen R; Gray NS; Yates JR; Lee JD
Oncogene; 2013 Jun; 32(26):3156-64. PubMed ID: 22869143
[TBL] [Abstract][Full Text] [Related]
9. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
10. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
11. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
14. Subcellular distribution of p53 and p73 are differentially regulated by MDM2.
Gu J; Nie L; Kawai H; Yuan ZM
Cancer Res; 2001 Sep; 61(18):6703-7. PubMed ID: 11559539
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the degradation function of Mdm2.
Kubbutat MH; Ludwig RL; Levine AJ; Vousden KH
Cell Growth Differ; 1999 Feb; 10(2):87-92. PubMed ID: 10074902
[TBL] [Abstract][Full Text] [Related]
16. Human-herpesvirus-8-encoded K8 protein colocalizes with the promyelocytic leukemia protein (PML) bodies and recruits p53 to the PML bodies.
Katano H; Ogawa-Goto K; Hasegawa H; Kurata T; Sata T
Virology; 2001 Aug; 286(2):446-55. PubMed ID: 11485412
[TBL] [Abstract][Full Text] [Related]
17. P53 and PML: new partners in tumor suppression.
Gottifredi V; Prives C
Trends Cell Biol; 2001 May; 11(5):184-7. PubMed ID: 11316590
[No Abstract] [Full Text] [Related]
18. Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx.
Zhao LY; Colosimo AL; Liu Y; Wan Y; Liao D
J Virol; 2003 Nov; 77(21):11809-21. PubMed ID: 14557665
[TBL] [Abstract][Full Text] [Related]
19. The human oncoprotein MDM2 uses distinct strategies to inhibit transcriptional activation mediated by the wild-type p53 and its tumor-derived mutants.
Brown DR; Deb D; Frum R; Hickes L; Munoz R; Deb S; Deb SP
Int J Oncol; 2001 Mar; 18(3):449-59. PubMed ID: 11179471
[TBL] [Abstract][Full Text] [Related]
20. Cross talk between PML and p53 during poliovirus infection: implications for antiviral defense.
Pampin M; Simonin Y; Blondel B; Percherancier Y; Chelbi-Alix MK
J Virol; 2006 Sep; 80(17):8582-92. PubMed ID: 16912307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
